Omada Health's Commitment to Transforming Weight Loss Outcomes
Omada Health, a pioneer in virtual healthcare, has been making waves in the health and wellness sector by showcasing significant improvements in patient outcomes, particularly for individuals using GLP-1 medications for weight management. This is crucial in today's world where effective weight management solutions are in high demand.
Key Findings from ObesityWeek 2025
During the recent ObesityWeek 2025, Omada Health unveiled two detailed analyses demonstrating the impact of its behavior change programs on members currently or previously using GLP-1 medications. The findings revealed that participation in Omada's programs can lead to enhanced weight loss outcomes and improved medication adherence. These insights contribute valuable real-world evidence that supports the efficacy of lifestyle interventions in conjunction with medical treatments.
Improving Medication Persistence
The first analysis focused on the persistence of GLP-1 medication among 1,124 Omada members enrolled in the Enhanced GLP-1 Care Track. The data indicated that members involved in the program exhibited remarkable persistence, with 84% maintaining their medication over a 24-week period. This statistic highlights the importance of consistent engagement with support systems. Those who engaged more frequently achieved a 12.1% weight loss compared to a lesser 7.4% for those who disengaged earlier.
Long-Term Weight Management after Discontinuation
Equally important was the second study, which evaluated 816 Omada members post-GLP-1 discontinuation. The results were striking, showing that one year after stopping the medication, members experienced an average weight change of only 0.8%. Typically, clinical trials demonstrate significant weight gain after medication cessation; however, 63.2% of Omada's members either maintained or continued to lose weight 12 months after discontinuation.
The Role of Omada's Support Programs
Omada's evidence suggests that dedicated behavioral support can significantly improve adherence to GLP-1 therapies and aid in maintaining weight loss. This dual approach—not just relying on medications but also incorporating lifestyle modification—has the potential to reshape how we approach obesity treatment. Omada Health's President, Wei-Li Shao, emphasized the critical nature of this synergy, advocating for more healthcare resources to be directed toward lifestyle interventions that work alongside pharmacological treatments.
About Omada Health
With a reputation as a leading virtual-first healthcare provider, Omada Health combines technology with behavior change science to tackle chronic health conditions like obesity, diabetes, and hypertension. It takes a comprehensive approach that includes tailored support for members, ensuring they have the tools necessary for lifelong health management.
Boasting over a decade of experience and multiple peer-reviewed studies, Omada demonstrates that its structured support can significantly impact health outcomes and minimize healthcare costs, which is increasingly vital in today’s medical landscape.
Frequently Asked Questions
What are GLP-1 medications?
GLP-1 medications are a class of drugs used to help control blood sugar levels and promote weight loss in individuals with obesity or type 2 diabetes.
How does Omada's program enhance GLP-1 medication effectiveness?
Omada's program offers personalized support and lifestyle modification strategies that improve medication adherence and enhance overall health outcomes for users.
What were the key findings shared at ObesityWeek 2025?
The key findings revealed that patients engaged in Omada's programs experienced significantly higher medication persistence and less weight regain after stopping GLP-1 treatments.
How does Omada support its members?
Omada provides tailored coaching, educational resources, and collaborative tools to help members change behaviors and sustain health improvements over time.
Why is behavioral support essential in obesity treatment?
Behavioral support addresses the lifestyle and psychological factors affecting weight management, making it an integral part of effective obesity treatment alongside medications.
